Patents by Inventor Hua Hao

Hua Hao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10235874
    Abstract: A remote control method, and a remote control system and a gateway for implementing the method are provided. The method includes receiving, by a remote control device, a plurality of ultra-wideband signals transmitted by a main control device to calculate position data; calculating, by the remote control device, rotation vector data according to detection data of the remote control device; transmitting, by the remote control device, the rotation vector data and the position data to the main control device to allow the main control device to identify an electronic device the remote control device aims at and transmit control information corresponding to the electronic device to the remote control device according to the rotation vector data and the position data; and displaying, by the remote control device, a control interface for controlling the electronic device according to the received control information.
    Type: Grant
    Filed: May 8, 2018
    Date of Patent: March 19, 2019
    Assignee: PEGATRON CORPORATION
    Inventors: Nien-Chih Wang, Wei-Hua Hao, Tien-Chu Chang
  • Publication number: 20190065343
    Abstract: A computer-implemented method of training, using a computer log file, an application error prediction engine to identify one or more application errors includes parsing the computer log file into a plurality of data sets. Each data set is associated with a unique computing session having a session identifier and ending in an application or. The method also includes extracting, from each data set, values for a specified set of parameters in each data set. The method also includes encoding the extracted values for each data set into a corresponding data structure. The method also includes generating, for each data structure, a corresponding vector, the corresponding vectors collectively forming a matrix. The method also includes calculating, based on the matrix, a set of clusters, each cluster corresponding to a known error type, the set of clusters used to create a model used to identify new error types.
    Type: Application
    Filed: August 29, 2017
    Publication date: February 28, 2019
    Inventors: Pu Li, Maohua Sun, Hua Hao, Junmei Liu, Yuanjun Liu, Yucai Yang
  • Publication number: 20180322774
    Abstract: A remote control method, and a remote control system and a gateway for implementing the method are provided. The method includes receiving, by a remote control device, a plurality of ultra-wideband signals transmitted by a main control device to calculate position data; calculating, by the remote control device, rotation vector data according to detection data of the remote control device; transmitting, by the remote control device, the rotation vector data and the position data to the main control device to allow the main control device to identify an electronic device the remote control device aims at and transmit control information corresponding to the electronic device to the remote control device according to the rotation vector data and the position data; and displaying, by the remote control device, a control interface for controlling the electronic device according to the received control information.
    Type: Application
    Filed: May 8, 2018
    Publication date: November 8, 2018
    Applicant: PEGATRON CORPORATION
    Inventors: Nien-Chih Wang, Wei-Hua Hao, Tien-Chu Chang
  • Publication number: 20170360894
    Abstract: The disclosure relates to a dosage forms and combinations of dosage forms useful for effective oral administration of drugs which are otherwise unsuitable for oral administration, owing to acid- and/or protease-mediated degradation. The dosage forms include a self-microemulsifying drug delivery system (SMEDDS) with which the drug is combined and an antacid. When co-administered to a mammal, the dosage form(s) can prevent drug degradation by the strong acid and digestive enzymes normally present in the gastric environment, and can improve water-soluble drug absorption in gastrointestinal (GI) tract. The dosage forms can be used to effectively administer insulin by an oral route, for example, such as in the form of a powder that can be stored for long periods and reconstituted with water or another fluid shortly before administration.
    Type: Application
    Filed: November 4, 2015
    Publication date: December 21, 2017
    Applicant: InnoPharmax, Inc.
    Inventors: Yu-Tsai YANG, Jong-Jing WANG, Pei-Jing HSU, Li-Chien CHANG, Wei-Hua HAO, Chang-Shan HSU
  • Publication number: 20170348341
    Abstract: The disclosure relates to compositions and methods for treatment, such as inducing regression or inhibiting growth, of tumors in a patient such as a human. Use of gemcitabine, including in self-emulsifying orally administered dosage forms for these purposes is described. Gemcitabine is orally administered in a metronomic manner, which involves repeatedly administering a therapeutic amount of gemcitabine, being a fraction of the maximum tolerated dose, over an extended period of time, preferably on a non-interrupted schedule of weeks, months, or indefinitely.
    Type: Application
    Filed: June 2, 2017
    Publication date: December 7, 2017
    Applicant: InnoPharmax, Inc.
    Inventors: Wei-Hua HAO, Shu-Ping Hsueh, Chang-Shan Hsu
  • Publication number: 20150196537
    Abstract: The present invention provides an oral self micro-emulsifying pharmaceutical composition of a hydrophilic drug or a pharmaceutically acceptable salt thereof which, in addition to the hydrophilic drug, one or more solvents for solving the hydrophilic drug to form a drug-solvent solution and a surfactant system, further comprises one or more hydrophilic carrier which are compatible with said drug-solvent solution and the surfactant system. The oral self micro-emulsifying pharmaceutical composition of the invention exhibits comparative bioavailability to that of the hydrophilic drug through injection and is stable during storage. A method for preparing the oral self micro-emulsifying pharmaceutical composition is also provided.
    Type: Application
    Filed: March 26, 2015
    Publication date: July 16, 2015
    Applicant: Innopharmax, Inc.
    Inventors: Chang-Shan HSU, Wei-Hua HAO, Jong-Jing WANG, Tsung-Hsin LIN
  • Publication number: 20150153807
    Abstract: A method of reducing power consumption of an electronic device, the electronic device including a plurality of sensors, the method comprising the steps of: receiving sensed information from the sensors within a predetermined time period; judging whether the electronic device is under a stationary state within a predetermined time period according to a data variation of the sensed information received within the predetermined time period; and controlling a portion of the sensors to enter into a sleeping state or a low-power consumption state when the electronic device is under the stationary state within the predetermined time period.
    Type: Application
    Filed: November 26, 2014
    Publication date: June 4, 2015
    Inventors: Wei-Hua HAO, Nigel HSIUNG
  • Patent number: 8883207
    Abstract: A controlled release carvedilol formulation for less frequent, preferably once daily administration is described. The controlled release formulation comprises a therapeutically effective amount of carvedilol or a pharmaceutically acceptable salt thereof, a matrix forming polymer, a solubility enhancer and a pharmaceutically acceptable carrier. In one embodiment, a controlled release formulation having a therapeutically effective amount of carvedilol is contained in two or more subunits having different release profiles. The controlled release formulation is usable in the treatment and/or prophylaxis of one or more conditions such as cardiovascular disorders.
    Type: Grant
    Filed: September 29, 2010
    Date of Patent: November 11, 2014
    Assignees: TSH Biopharm Corporation Ltd., Innopharmax, Inc.
    Inventors: Wei-Hua Hao, Tsung-Hsin Lin, Ta-Chien Lu
  • Publication number: 20140120166
    Abstract: A composition of entacapone comprising entacapone or pharmaceutically acceptable salts, PVPK30 and SDS is disclosed in the present invention, wherein the mass ratio of entacapone: PVPK30: SDS is 1:0.05-0.6:0.06-0.1. The present invention also discloses preparative method and use of the composition of entacapone.
    Type: Application
    Filed: April 26, 2011
    Publication date: May 1, 2014
    Applicant: INNOPHARMAX, INC.
    Inventors: Wei-Hua Hao, Jong-Jing Wang, Hui-Yun Chen
  • Publication number: 20120245212
    Abstract: A controlled release carvedilol formulation for less frequent, preferably once daily administration is described. The controlled release formulation comprises a therapeutically effective amount of carvedilol or a pharmaceutically acceptable salt thereof, a matrix forming polymer, a solubility enhancer and a pharmaceutically acceptable carrier. In one embodiment, a controlled release formulation having a therapeutically effective amount of carvedilol is contained in two or more subunits having different release profiles. The controlled release formulation is usable in the treatment and/or prophylaxis of one or more conditions such as cardiovascular disorders.
    Type: Application
    Filed: September 29, 2010
    Publication date: September 27, 2012
    Applicants: INNOPHARMAX, INC., TSH BIOPHARM CORPORATION LTD.
    Inventors: Wei-Hua Hao, Tsung-Hsin Lin, Ta-Chien Lu
  • Publication number: 20100273730
    Abstract: The present invention provides an oral self micro-emulsifying pharmaceutical composition of a hydrophilic drug or a pharmaceutically acceptable salt thereof which, in addition to the hydrophilic drug, one or more solvents for solving the hydrophilic drug to form a drug-solvent solution and a surfactant system, further comprises one or more hydrophilic carrier which are compatible with said drug-solvent solution and the surfactant system. The oral self micro-emulsifying pharmaceutical composition of the invention exhibits comparative bioavailability to that of the hydrophilic drug through injection and is stable during storage. A method for preparing the oral self micro-emulsifying pharmaceutical composition is also provided.
    Type: Application
    Filed: April 26, 2010
    Publication date: October 28, 2010
    Applicant: INNOPHARMAX, INC.
    Inventors: Chang-Shan Hsu, Wei-Hua Hao, Jong-Jing Wang, Tsung-Hsin Lin
  • Publication number: 20090130198
    Abstract: The invention pertains to a self-emulsifying pharmaceutical composition containing a lipophilic drug, a surfactant, and a hydrophilic carrier. The invention also provides a method for making the pharmaceutical composition for increasing the bioavailability of a drug by self-emulsification.
    Type: Application
    Filed: November 21, 2007
    Publication date: May 21, 2009
    Applicant: INNOPHARMAX INC.
    Inventors: Wei-Hua Hao, Jong-Jing Wang, Chang-Shan Hsu
  • Patent number: 6627219
    Abstract: The present invention provides a oral capsule preparation, comprising a capsule prepared from a drug or the alkaline salt thereof, an oily compound or the alkaline salt thereof, an emulsifier and a polycarbon alcohol, together with an enteric coating disposed on the outer layer of the capsule; wherein said emulsifier is a composition of C6-18 organic fatty acid and an organic amine, or the mixture thereof. The invention also provides a method of preparing the oral capsule preparation of the invention.
    Type: Grant
    Filed: June 29, 2001
    Date of Patent: September 30, 2003
    Assignee: Pharmaceutical Industry Technology and Development Center
    Inventors: Wei-Hua Hao, Shih Min Chen
  • Publication number: 20030161872
    Abstract: The present invention provides a capsule which comprises (1) a capsule shell, and (2) a liquid core composition. The capsule shell comprises a pH-dependent polymer and optionally a plasticizer. The liquid core composition contains liquid up to 70% by volume. The pH of the liquid core composition is adjusted to or at a pH in which the pH-dependent polymer is insoluble. The liquid core composition is preferably a decoction or condensate of the decoction containing herbal extract. The present invention further provides methods for making the capsule.
    Type: Application
    Filed: January 4, 2002
    Publication date: August 28, 2003
    Inventors: Gan-Lin Chen, Wei-Hua Hao
  • Publication number: 20020076435
    Abstract: The present invention provides a oral capsule preparation, comprising a capsule prepared from a drug or the alkaline salt thereof, an oily compound or the alkaline salt thereof, an emulsifier and a polycarbon alcohol, together with an enteric coating disposed on the outer layer of the capsule; wherein said emulsifier is a composition of C6-18 organic fatty acid and an organic amine, or the mixture thereof. The invention also provides a method of preparing the oral capsule preparation of the invention.
    Type: Application
    Filed: June 29, 2001
    Publication date: June 20, 2002
    Inventors: Wei-Hua Hao, Shih Min Chen
  • Patent number: 5087038
    Abstract: An exercising device includes a beam having a lower end pivotally supported on a base. A handle portion is provided to an upper portion of the beam. A spring is biased between the beam and the base. The user may hold the handle portion and may actuate the beam to rotate against the spring so that the user can practice training muscle groups of his arm.
    Type: Grant
    Filed: March 7, 1991
    Date of Patent: February 11, 1992
    Inventors: Kuo-Hua Hao, Jui-Fang Hwang